Two “Unresolvable” Prescribing/Dispensing Red Flags Unfurled
The FDA Law Blog
JUNE 3, 2025
However, the 2022 Clinical Practice Guideline, which updated the CDCs 2016 Guideline, notes that its recommendations are voluntary and intended to be flexible to support, not supplant, individualized, patient-centered care. Recommendation 1. at Background.
Let's personalize your content